Cancer/Tumor
Profiling
Market
By
Technology,
Technique, - Global Industry Insights, Trends, Outlook,
and Opportunity Analysis, 2018–2026
Cancer profiling is a technique used to classify tumors more accurately, which helps in
predicting the patient’s clinical outcome. Cancer/Tumor profiling helps in identification of
genomic alteration, which aid to select an appropriate therapy for the treatment of cancer. This
technique reduces the trial and error process in diagnosis of cancer at various stages and
provide more precise and accurate information about clinical outcomes of cancer. Different tests
are used in the diagnosis of cancer such as laboratory test (blood and urine), biopsy, imaging
test (X-ray, MRI, PET/CT, and ultrasound), nuclear medicine scan, and lumber puncture, which
is unable to identify exact cause of cancer in early stages. This can be led to over-treatment of
cancer patients.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/967
According to the World Health Organization (WHO), nearly 1 in 6 deaths occurs due to cancer
and around 8.8 million people died from cancer worldwide in 2015. Increasing incidence and
prevalence of different cancers among individuals augmented the demand for accurate diagnosis
of cause in early stage of cancer.
Emergence of cancer profiling over traditional cancer diagnostic methods is expected to gain
growth of the Cancer/Tumor profiling market:
St. Jude Medical Center's Crosson Cancer Institute has joined Caris’ Precision Oncology Alliance
(POA) as its 17 th member in 2017. POA is established by Caris Life Sciences to promote the
appropriate use of molecular tool in diagnosis and treatment of cancer. The St. Jude Medical
Center's Crosson Cancer Institute will help Caris Life Sciences to develop standard and best
practices to make cancer treatment more effective and precise by advancing the use of tumor
profiling.